Tetraploid arrest with overexpressed non-mutated p53 in germ cell cancers: Relevance to their chemosensitivity and possible application in non-germ cell cancers

International Journal of Oncology

Volumn 11, Issue 6, 1997, Pages 1367-1371

  Nouri, A M E ^a,b   Oliver, R T D ^b  

^a Department of Medical Oncology ^*  (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Bcl 2; HSP70; p53; Testis germ cell cancer

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ARTICLE; BLADDER CARCINOMA; CHEMOSENSITIVITY; GERM CELL TUMOR; HEAD AND NECK CARCINOMA; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEMINOMA; SQUAMOUS CELL CARCINOMA; TETRAPLOIDY;

EID: 0030856177     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Lane DP: p53, guardian of the genome. Nature 358: 15-16, 1992.
2. Bishop JM: Molecular themes in oncosenesis. Cell 64: 235-248, 1991.
3. Alberts B, Bray D, Lewis J, Raff M, Roberts K and Watson J: Molecular biology of the cell. Vols 3 and 4. Garland, New York, pp 1281-1289, 1994.
4. Davidoff AM, Iglehart JD and Marks JR: Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc Natl Acad Sci USA 89: 3439-3442, 1992.
5. Esrig D, Elmajian D, Groshen S, et al: Accumulation of nuclear p53 and tumor progression in bladder cancer. N Encl J Med 331: 1259-1264, 1994.